293 related articles for article (PubMed ID: 27125747)
1. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
Xie J; Wu YL; Huang CL
Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
[TBL] [Abstract][Full Text] [Related]
2. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
Xie J; Yoon J; An SW; Kuro-o M; Huang CL
J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
[TBL] [Abstract][Full Text] [Related]
3. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
Grabner A; Faul C
Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
[TBL] [Abstract][Full Text] [Related]
4. New insights into the FGF23-Klotho axis.
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
[TBL] [Abstract][Full Text] [Related]
5. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
7. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
8. Klotho and chronic kidney disease.
Hu MC; Kuro-o M; Moe OW
Contrib Nephrol; 2013; 180():47-63. PubMed ID: 23652549
[TBL] [Abstract][Full Text] [Related]
9. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.
Navarro-García JA; Salguero-Bodes R; González-Lafuente L; Martín-Nunes L; Rodríguez-Sánchez E; Bada-Bosch T; Hernández E; Mérida-Herrero E; Praga M; Solís J; Arribas F; Bueno H; Kuro-O M; Fernández-Velasco M; Ruilope LM; Delgado C; Ruiz-Hurtado G
BMC Med; 2022 Jan; 20(1):14. PubMed ID: 35042527
[TBL] [Abstract][Full Text] [Related]
10. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
11. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
12. FGF23 and Klotho in chronic kidney disease.
Olauson H; Larsson TE
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
[TBL] [Abstract][Full Text] [Related]
13. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
de Seigneux S; Martin PY
Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
Nitta K; Nagano N; Tsuchiya K
Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
[TBL] [Abstract][Full Text] [Related]
15. αKlotho and Chronic Kidney Disease.
Neyra JA; Hu MC
Vitam Horm; 2016; 101():257-310. PubMed ID: 27125746
[TBL] [Abstract][Full Text] [Related]
16. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
17. FGF23 and klotho at the intersection of kidney and cardiovascular disease.
Edmonston D; Grabner A; Wolf M
Nat Rev Cardiol; 2024 Jan; 21(1):11-24. PubMed ID: 37443358
[TBL] [Abstract][Full Text] [Related]
18. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
[TBL] [Abstract][Full Text] [Related]
19. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
[TBL] [Abstract][Full Text] [Related]
20. αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats.
Suassuna PGA; Cherem PM; de Castro BB; Maquigussa E; Cenedeze MA; Lovisi JCM; Custódio MR; Sanders-Pinheiro H; de Paula RB
Exp Biol Med (Maywood); 2020 Jan; 245(1):66-78. PubMed ID: 31847589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
